SLAS Discovery

Papers
(The median citation count of SLAS Discovery is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Outline and background for the EU-OS solubility prediction challenge176
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening70
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery54
Bioassay protocol metadata annotation: Proposed standards adoption54
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei40
Ex vivo discovery of synergistic drug combinations for hematologic malignancies38
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature36
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection26
Protocol for 3D screening of lung cancer spheroids using natural products25
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin24
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay24
Emerging drug discovery ecosystems18
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components18
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling17
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer17
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules16
Role Of Vaccines Against COVID-19 Pandemic16
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern16
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines15
Drug repurposing screen for the rare disease ataxia-telangiectasia15
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis15
Screening for molecular glues – Challenges and opportunities14
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice14
Comparative analysis of antibody-mediated loss-of-function versus gene knock-out and knock-down14
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors13
In Memoriam13
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening12
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicals12
Protocol to develop A 3D tumor model for drug testing applications12
High-Throughput cell-based immunofluorescence assays against influenza11
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells11
Bonferroni’s method, not Tukey’s, should be used to control the total number of false positives when making multiple pairwise comparisons in experiments with few replicates10
Development of a live cell assay for the zinc transporter ZnT810
An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites10
A perspective on the discovery of enzyme activators10
VOC analysis for rapid, early detection of bacteria, mold, and mycoplasma in cell and tissue cultures9
Automated high-throughput, high-content 3D imaging of intact pancreatic islets9
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch9
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc9
A high throughput assay to identify modulators of Death Receptor 3 (DR3)9
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons9
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library9
Publisher's Note9
A robust CETSA data analysis automation workflow for routine screening9
Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders9
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]9
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies9
A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies9
SLAS discovery - special issue - biomolecular condensate drug discovery9
Creating a more strategic small molecule biophysical hit characterization workflow8
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems8
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant8
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models8
Using chemical and biological data to predict drug toxicity8
WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin7
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes7
Identification of novel inflammasome inhibitors via cellular NLRP3 target engagement assays7
Protocols in drug discovery7
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening7
Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery7
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance7
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models7
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay7
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols7
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase7
Characterisation of high throughput screening outputs for small molecule degrader discovery7
High-throughput screening of ALS patient iPSC-derived spinal motor neurons identifies novel compounds that increase neurofilament light chain expression7
Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells6
Robustness of NanoBiT luciferase complementation technology in the presence of widely used kinase inhibitors6
High-throughput screening identifies non-nucleoside inhibitors of the SARS-CoV-2 polymerase with novel mechanisms6
Antimicrobial resistance: Linking molecular mechanisms to public health impact6
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids6
A biochemical screening platform to target chromatin states using condensates as a tool6
MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling6
Corelet™ platform: Precision high throughput screening for targeted drug discovery of biomolecular condensates5
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS5
Optimising cell-based bioassays via integrated design of experiments (ixDoE) - A practical guide5
Drug discovery efforts at George Mason University5
High-throughput approaches to uncover synergistic drug combinations in leukemia5
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-25
Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives5
Graph neural networks for the identification of novel inhibitors of a small RNA5
Validation, optimization, and quality assessment of a neuro-behavioral in vivo assay for phenotypic high-content evaluation of anesthetics5
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors5
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction5
Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase5
Discovery and validation of small molecule stabilizers of mutant triose phosphate isomerase (TPI) as potential lead candidates for TPI deficiency5
Compound management in a virtual research organization: The cornerstone of a reliable MMV discovery engine5
PCIM: Learning pixel attributions via pixel-wise channel isolation mixing in high content imaging5
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling5
Development of a live cell assay for real-time monitoring the interactions between the Hippo pathway components 14-3-3 and TAZ5
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors4
Alternate dyes for image-based profiling assays4
Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction4
Advancing the development of TRIP13 inhibitors: A high-throughput screening approach4
Orthogonal temperature-related intensity change (TRIC) and TR-FRET as a high-throughput screening platform for the discovery of SLIT2 binders: A proof-of-concept approach4
High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy4
The openOCHEM consensus model is the best-performing open-source predictive model in the First EUOS/SLAS joint compound solubility challenge4
Point-of-use, automated fabrication of a 3D human liver model supplemented with human adipose microvessels4
Automated quality control tool for high-content imaging data by building 2D prediction intervals on reference biosignatures4
Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay4
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA14
Development of a NanoBiT based high throughput screening assay for discovery of NOS1-NOS1AP interaction inhibitors4
Development of a BRET based chloride biosensor for high throughput screening of KCC2 modulators4
Mathematical relationships between control group variability and assay quality metrics4
HTS discovery of PARP1-HPF1 complex inhibitors in cancer4
1st EU-OPENSCREEN/SLAS data mining competition to predict compounds solubility4
A high throughput assay for phosphoribosylformylglycinamidine synthase4
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library4
A multi-parametric high throughput assay for detecting beta-cell proliferation in dispersed primary islets4
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library4
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors4
The role of m6A in lipid metabolism-related diseases4
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins4
Magnetic three-dimensional bioprinting protocol for salivary gland mucoepidermoid carcinoma tumoroid culture3
WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines3
High-throughput method to analyze the cytotoxicity of CAR-T Cells in a 3D tumor spheroid model using image cytometry3
Micro/nano topological modification of TiO2 nanotubes activates Thy-1 signaling to control osteogenic differentiation of stem cells3
High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle3
Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer3
Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications3
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates3
MT1G activation in dopaminergic neurons identifies chelators and their relationships to cytotoxicity3
BRET measurement on CCD camera-based microtiter plate readers3
Streamlining cellular thermal shift assay for ultra-high throughput screening3
Identification of a small molecule CAPON binder using affinity selection-mass spectrometry screening3
Identification of chemicals breaking the USP8 interaction with its endocytic substrate CHMP1B3
High-content immunofluorescence assay detecting PD-L1 expression changes in head and neck cancer patient-derived cultures3
A neuronal cell-based reporter system for monitoring the activity of HDAC23
A mechanism of action-reflective, dual cell-based bioassay for determining the bioactivity of sclerostin-neutralizing antibodies3
Beyond fluorescence: A critical look at AI-powered brightfield analysis for T-cell killing assays3
Structure-activity relationships of thiadiazole agonists of the human secretin receptor3
Corrigendum to “Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology” [SLAS Discovery, Volume 27 (2022) P140-147/2472-5552]3
ATPase activity profiling of three human DExD/H-box RNA helicases3
Toxicity evaluation of pharmaceutical drugs and quantum dots (QDs) using zebrafish embryos – A comprehensive review3
Utilising acoustic mist ionisation mass spectrometry to identify redox cycling compounds in high throughput screening outputs3
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids3
0.044158935546875